Research
Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone
-
* Corresponding author: Linda B Piller lpiller@sph.uth.tmc.edu
Current Controlled Trials in Cardiovascular Medicine 2002, 3:10 doi:10.1186/1468-6708-3-10
No comments have yet been made on this article.